NCT00744263 Study Evaluating the Effiacy of a 13-Valent Pneumococcal Conjugate Vaccine (13vPnC) in Adults Status COMPLETED Phase PHASE4
NCT00743847 A 6-Week Multicenter Trial Of Varenicline Tartrate For Cognitive Impairment In Subjects With Schizophrenia Status WITHDRAWN Phase PHASE2
NCT00743652 Study Evaluating the Impact of the 13-valent Pneumococcal Conjugate Vaccine (13vPnC) in Alaskan Native Children. Status COMPLETED Phase PHASE3
NCT00743613 Predicting Peripheral Arterial Disease in Men With Erectile Dysfunction Status COMPLETED Phase N/A
NCT00743587 A Study To Assess The Ability Of Tramadol, Naproxen And Oxycodone To Affect The Pain Thresholds Of Patients With Osteoarthritis Of The Thumb Status COMPLETED Phase PHASE1
NCT00741884 A Study to Evaluate the Safety and Efficacy of Three Doses of a Controlled Release Formulation of Varenicline for Smoking Cessation Status WITHDRAWN Phase PHASE2
NCT00741702 Diabetes Risk Evaluation and Microalbuminuria in Saskatchewan First Nations Peoples Status COMPLETED Phase NA
NCT00739947 Arthroscopic Surgical Outcome Study In Subjects With Rotator Cuff Tears Status COMPLETED Phase N/A
NCT00739934 Study Of The Pharmacokinetics And Safety Of Voriconazole In Children 2 To 11 Years Old Who Are At High Risk For Systemic Fungal Infection Status COMPLETED Phase PHASE2
NCT00739739 An Effectiveness And Safety Study Of PD 0299685 For The Treatment Of Symptoms Associated With Interstitial Cystitis Status COMPLETED Phase PHASE2
NCT00738738 6-Month Open-Label Safety Study Of PD 0332334 In Elderly Patients With Generalized Anxiety Disorder (GAD) Status WITHDRAWN Phase PHASE3
NCT00737113 Recombinant Human Growth Hormone (RH-GH) For Accelerating Immune Reconstitution Post Unrelated Cord Blood Transplant Status TERMINATED Phase PHASE1
NCT00736528 A Phase I, Multiple Dose Study of PF-04447943 in Healthy Elderly Volunteers Status TERMINATED Phase PHASE1
NCT00735904 Trial Of AG-013736, Cisplatin, And Gemcitabine For Patients With Squamous Non-Small Cell Lung Cancer Status COMPLETED Phase PHASE2
NCT00735267 A 52-Week Open-Label Safety Study of PD 0332334 in Subjects With Generalized Anxiety Disorder (GAD) Status TERMINATED Phase PHASE3
NCT00735072 Maraviroc as an Immunomodulatory Drug for Antiretroviral-treated HIV Infected Patients Exhibiting Immunologic Failure Status COMPLETED Phase PHASE4